Psychiatry Archives - Page 2 of 6

Dec 26 2022

Alcohol Withdrawal – Should We Reach for Phenobarbital?

Pharmacy/Pharmacology, Psychiatry

Spoon Feed
Hospital adoption of phenobarbital for severe alcohol withdrawal syndrome (SAWS) was associated with lower rates of invasive mechanical ventilation (IMV).

Source
Phenobarbital for Severe Alcohol Withdrawal Syndrome: A Multicenter Retrospective Cohort Study. Am J Respir Crit Care Med. 2022 Nov 1;206(9):1171-1174. doi: 10.1164/rccm.202203-0466LE.

Dec 02 2022

How to Diagnose a Functional Neurological Disorder – Inconsistency and Incongruence

Neurology, Psychiatry

Spoon Feed
Inconsistency and incongruence are two keys to diagnosing a functional neurological disorder. The video demonstration really helps sort this out.

Source
Inconsistency and incongruence: the two diagnostic pillars of functional movement disorder. Lancet. 2022 Jul 23;400(10348):328. doi: 10.1016/S0140-6736(22)01184-9.

Sep 05 2022

Let’s Talk About Long COVID – What Is It?

Infectious Disease, Psychiatry, Wellness

Spoon Feed
Patients with long COVID had a host of symptoms, poorer quality of life, and more anxiety and depression, but they did not have a specific cause identified for symptoms despite a comprehensive exam and battery of tests.

Source
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings. Ann Intern Med. 2022 Jul;175(7):969-979. doi: 10.7326/M21-4905. Epub 2022 May 24.

Jul 08 2022

Can We Use Droperidol for Pediatric Agitation?

Pediatrics, Pharmacy/Pharmacology, Psychiatry

Spoon Feed
This systematic review suggests that droperidol is both safe and effective for treating agitation in the pediatric population.

Source
A Systematic Review of the Effectiveness and Safety of Droperidol for Pediatric Agitation in Acute Care Settings. Acad Emerg Med. 2022 May 1. doi: 10.1111/acem.14515. Online ahead of print.

Feb 25 2022

Droperidol’s Reintroduction | A Risk-Benefit Analysis

GI, Pharmacy/Pharmacology, Psychiatry

Spoon Feed New research on droperidol shows that it is a safe and effective medication for a multitude of common ED presentations, despite an FDA black box warning for QTc prolongation in 2001.

Oct 06 2021

Can Opioids in the Critically Ill Induce Delirium?

Critical Care, Pain/Sedation/Procedure, Psychiatry

Spoon Feed The quick answer is yes. This has been a debate in the critical care and pain literature for quite some time, but according to this trial, we finally have our answer - receiving opioids in the ICU increases the odds of delirium in a dose-dependent fashion

Sep 24 2021

Ketamine vs Midazolam-Haloperidol for Acute Agitation

Pain/Sedation/Procedure, Pharmacy/Pharmacology, Psychiatry

Spoon Feed Use of intramuscular ketamine for patients with severe agitation resulted in significantly shorter time to sedation compared to a combination of intramuscular midazolam and haloperidol (5.8 vs 14.7 minutes).

Sep 23 2021

IM Droperidol versus Olanzapine for the Agitated Patient – Which to Choose?

Pain/Sedation/Procedure, Pharmacy/Pharmacology, Psychiatry

Spoon Feed There was no difference between IM droperidol and IM olanzapine in time to adequate sedation for the acutely agitated ED patient. Droperidol carried a slightly higher risk of extrapyramidal effects.

Apr 15 2021

Return Rates After Opioids for Back Pain in the Emergency Department

Pain/Sedation/Procedure, Pharmacy/Pharmacology, Psychiatry, Sports Medicine

Spoon Feed Patients who received opioids in the ED for low back pain were significantly more likely to return to the ED within 30 days for the same complaint when compared to those who received only NSAIDs, acetaminophen, or a combination of the two.

Mar 17 2021

Risk of EMS Transport Refusal After Naloxone

EMS, Psychiatry, Toxicology

Spoon Feed Patient refusal of EMS transport after opioid overdose is associated with increased risk of repeat pre-hospital encounter for non-fatal overdose.

Newer posts Older posts